Investing.com - Neuroone Medical (NASDAQ: NMTC) reported first quarter EPS of $0.010, $0.12 better than the analyst estimate of $-0.110. Revenue for the quarter came in at $3.6M versus the consensus estimate of $1.8M.
Neuroone Medical's stock price closed at $2,210. It is up 2.04% in the last 3 months and down -5.96% in the last 12 months.
See Neuroone Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Neuroone Medical's Financial Health score is " performance".
Check out Neuroone Medical's recent earnings performance, and Neuroone Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar